Ranbaxy wins UK SFO case
Ranbaxy Laboratories Limited (Ranbaxy) announced that the UK Serious Fraud Office’s (SFO) prosecution of its UK subsidiary, Ranbaxy (UK) Limited (RUKL), has been quashed by the English Crown Court. The Court also declined an application by the SFO for permission to appeal to the English Court of Appeal, although the SFO retains a right to appeal to the Court of Appeal directly.
Ranbaxy welcomes the decision of the English Crown Court.
Ranbaxy is a responsible company committed to providing high quality generic medicines at affordable prices to its customers and patients throughout the world.
Tags: calls, daytrading, free calls, intraday, tips
Similar Posts:
Latest Query
- by Sam
Search Our Archives
Research Desk
- Stocks Trading above their 50 day moving average - DMA In Stock Research
- Download free Ebooks based on Technical Analysis In Personal Training
- TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
- TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
- Charting Pathsala - Your guide to Techincals In Technical Analysis